ADL 100101

Drug Profile

ADL 100101

Alternative Names: ADL 0101; ADL 10-0101

Latest Information Update: 22 Aug 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Adolor Corporation
  • Class
  • Mechanism of Action Opioid kappa receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pruritus; Visceral pain

Most Recent Events

  • 10 Jul 2006 Discontinued - Phase-I for Pruritus in USA (Topical)
  • 10 Jul 2006 Discontinued - Phase-II for Visceral pain in USA (IV-injection)
  • 10 Jul 2006 Discontinued - Preclinical for Pruritus in USA (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top